In 2016, we topped the Access to Medicine Index for the fifth consecutive time since it began in 2008. The index is an independent measure of the top 20 pharmaceutical companies’ efforts to improve access to healthcare in developing countries. Read more: http://bit.ly/2nWJ4vq
